Explore 3 Stock Ideas & Industry Insights Download Free Report

Stocks

Phillips Edison & Company to Present at Nareit REITweek 2025 Investor Conference

Phillips Edison & Company, Inc. CINCINNATI, May 15, 2025 (GLOBE NEWSWIRE) -- Phillips Edison & Company, Inc. (Nasdaq: PECO) (“PECO” or the “Company”), one of the nation’s largest owners and operators of high-quality, grocery-anchored neighborhood shopping centers, today announced that Chairman and Chief Executive …

EODHD | 16 May 2025

PLBY Group Reports First Quarter 2025 Financial Results

Q1 Revenue of $28.9 Million, Net Loss of $9.0 Million, an Improvement of $7.4 Million, Adjusted EBITDA of $2.4 Million, an Improvement of $5.0 Million LOS ANGELES, May 15, 2025 (GLOBE NEWSWIRE) -- PLBY Group, Inc. (NASDAQ: PLBY) (“PLBY Group” or the “Company”), a …

EODHD | 16 May 2025

Quantum-Si Reports First Quarter 2025 Financial Results

Launches and Delivers First Platinum® Pro Units Announces New Library Preparation Development Program BRANFORD, Conn., May 15, 2025--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced financial results for the first quarter ended March 31, 2025. Press …

EODHD | 16 May 2025

Reviva Reports First Quarter 2025 Financial Results and Recent Business Highlights

– 446 participants completed the brilaroxazine long-term open-label extension (OLE) trial with 156 completing one-year and 301 completing six months of treatment – – Full data set from RECOVER OLE highlighting clinical response, safety, efficacy, adherence, and biomarker data expected in Q2 2025 – …

EODHD | 16 May 2025

Travere Therapeutics Announces FDA Acceptance of sNDA for FILSPARI® (sparsentan) in FSGS

PDUFA target action date of January 13, 2026 If approved, FILSPARI would be the first and only FDA-approved treatment for FSGS, a rare kidney condition and a leading cause of kidney failure SAN DIEGO, May 15, 2025--(BUSINESS WIRE)--Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced …

EODHD | 16 May 2025

V2X, INC. ANNOUNCES SALE OF 2,000,000 SHARES OF COMMON STOCK IN SECONDARY OFFERING BY VERTEX AEROSPACE

MCLEAN, Va., May 15, 2025 /PRNewswire/ -- V2X, Inc. (NYSE: VVX) ("V2X"), a leading provider of global mission solutions, announced today the sale of 2 million shares of its common stock on an underwritten basis by Vertex Aerospace Holdco LLC ("Vertex Aerospace"). In addition, …

EODHD | 16 May 2025

Expion360 Reports First Quarter 2025 Financial Results

Q1 2025 Revenue Growth of 111% Driven by New Products and Technologies 5th Consecutive Quarter of Robust Revenue Growth Began Shipping e360 Home Energy Storage Solutions REDMOND, Ore., May 15, 2025 (GLOBE NEWSWIRE) -- Expion360 Inc. (Nasdaq: XPON) (“Expion360” or the “Company”), an industry …

EODHD | 16 May 2025

Fold Holdings Inc. (NASDAQ: FLD) Announces First Quarter 2025 Results

Revenue: $7.1 million, 44% YoY increase Bitcoin Treasury Holdings: 1,490 BTC, ~50% increase from Q4 2024 Launched Bitcoin Gift Card with access to network of thousands of retailers New accounts up over 300% YoY and platform volumes up 67% YoY PHOENIX, May 15, 2025 …

EODHD | 16 May 2025

Aristocrat Leisure First Half 2025 Earnings: EPS Beats Expectations, Revenues Lag

Aristocrat Leisure (ASX:ALL) First Half 2025 Results Key Financial Results Revenue: AU$3.03b (up 8.7% from 1H 2024). Net income: AU$511.0m (down 22% from 1H 2024). Profit margin: 17% (down from 23% in 1H 2024). The decrease in margin was driven by higher expenses. EPS: …

EODHD | 16 May 2025

OSIS Q1 Earnings Call: Higher Service Revenues and Backlog Support Guidance Amid Tariff Uncertainty

Security and healthcare technology company OSI Systems (NASDAQ:OSIS) reported Q1 CY2025 results beating Wall Street’s revenue expectations , with sales up 9.6% year on year to $444.4 million. The company expects the full year’s revenue to be around $1.7 billion, close to analysts’ estimates. …

EODHD | 16 May 2025